Gyre Therapeutics (GYRE) Loans and Notes Receivables (2022 - 2025)
Historic Loans and Notes Receivables for Gyre Therapeutics (GYRE) over the last 4 years, with Q3 2025 value amounting to $693000.0.
- Gyre Therapeutics' Loans and Notes Receivables rose 66153.85% to $693000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $693000.0, marking a year-over-year increase of 66153.85%. This contributed to the annual value of $4.4 million for FY2024, which is 102416.45% up from last year.
- As of Q3 2025, Gyre Therapeutics' Loans and Notes Receivables stood at $693000.0, which was up 66153.85% from $499000.0 recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Loans and Notes Receivables registered a high of $4.4 million during Q4 2024, and its lowest value of $91000.0 during Q3 2024.
- Over the past 4 years, Gyre Therapeutics' median Loans and Notes Receivables value was $499000.0 (recorded in 2025), while the average stood at $1.2 million.
- Per our database at Business Quant, Gyre Therapeutics' Loans and Notes Receivables crashed by 7444.15% in 2023 and then surged by 102416.45% in 2024.
- Over the past 4 years, Gyre Therapeutics' Loans and Notes Receivables (Quarter) stood at $1.5 million in 2022, then plummeted by 74.44% to $389000.0 in 2023, then surged by 1024.16% to $4.4 million in 2024, then tumbled by 84.15% to $693000.0 in 2025.
- Its Loans and Notes Receivables stands at $693000.0 for Q3 2025, versus $499000.0 for Q2 2025 and $2.1 million for Q1 2025.